These results indicate that inhibition of β-Catenin and PSG expression by targeting LEF/TCF proteins using O’PROTAC can effectively block the growth of TMPRSS2-ERG fusion and GOF p53 mutant positive PCa in vitro and in vivo. The gene discussed is ERG; the disease is posterior cortical atrophy.